The gut microbiota in neuropsychiatric disorders

• Autorzy: Grochowska M. , Wojnar M. , Radkowski M.
• Języki publikacji: EN

Abstrakty

EN

The purpose of this review is to summarize current knowledge about the gut microbiota in neuropsychiatric disorders. It is estimated that the human gut is colonized by up to 1018 microorganisms, mostly anaerobic bacteria. The gut microbiome is responsible for multiple functions, e.g. tightness of the intestine barrier, digestion and absorption. The correlation between gut dysbiosis and development of psychiatric, autoimmune and allergic diseases as well as bidirectional communication between brain and gut microflora have been shown. Recent findings suggest that specific bacteria can be involved in the development of clinical conditions, such as Autism Spectrum Disorders, depression and schizophrenia, and microbiota may be a target for therapeutic intervention providing novel treatment strategies.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2018
• Tom: 78
• Numer: 2
• Opis fizyczny: p.69-81,ref.

Twórcy

autor

Grochowska M.

• Department of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland

autor

Wojnar M.

• Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland

autor

Radkowski M.

• Department of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland

Bibliografia

• Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J (2014) The placenta harbors a unique microbiome. Sci Transl Med 6: 237ra265.
• Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA (2011) Gastrointestinal flora and gastrointestinal status in children with autism‑comparisons to typical children and correlation with autism severity. BMC Gastroenterol 11: 22.
• Aguilera M, Vergara P, Martinez V (2013) Stress and antibiotics alter lumi‑ nal and wall‑adhered microbiota and enhance the local expression of visceral sensory‑related systems in mice. Neurogastroenterol Motil 25: e515–529.
• Ait‑Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L, Houdeau E, Fioramonti J, Bueno L, Theodorou V (2012) Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37: 1885–1895. Andoh A, Fujiyama Y (2006) Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease. World J  Gastroenterol 12: 4452–4460.
• Arndt TL, Stodgell CJ, Rodier PM (2005) The teratology of autism. Int J Dev Neurosci 23: 189–199.
• Arneth BM (2017) Multiple Sclerosis and Schizophrenia. Int J Mol Sci 18. pii: E1760.
• Arumugam  M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM et al. (2011) Enterotypes of the human gut microbiome. Nature 473: 174–180.
• Ashwood P, Wakefield AJ (2006) Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol 173: 126–134.
• Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that reg‑ ulates fat storage. Proc Natl Acad Sci 101: 15718–15723.
• Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host‑bac‑ terial mutualism in the human intestine. Science 307: 1915–1920.
• Bangsgaard Bendtsen KM, Krych  L, Sorensen DB, Pang  W, Nielsen DS, Josefsen K, Hansen LH, Sorensen SJ, Hansen AK (2012) Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse. PLoS One 7: e46231.
• Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C (2012) gamma‑Am‑ inobutyric acid production by culturable bacteria from the human intes‑ tine. J Appl Microbiol 113: 411–417.
• Bengmark S (2013) Gut microbiota, immune development and function. Pharmacol Res 69: 87–113.
• Benros ME, Mortensen PB, Eaton WW (2012) Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci 1262: 56–66.
• Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, Malinowski P, Jackson  W, Blennerhassett P, Neufeld KA et al. (2010) Chronic gas‑ trointestinal inflammation induces anxiety‑like behavior and alters central nervous system biochemistry in mice. Gastroenterology 139: 2102–2112.
• Berk  M, Williams LJ, Jacka FN, O’Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M (2013) So depression is an in‑ flammatory disease, but where does the inflammation come from? BMC Med 11: 200.
• Bertrand J, Mars A, Boyle C, Bove F, Yeargin‑Allsopp M, Decoufle P (2001) Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 108: 1155–1161.
• Bezirtzoglou E, Tsiotsias A, Welling GW (2011) Microbiota profile in feces of breast‑ and formula‑fed newborns by using fluorescence in situ hybrid‑ ization (FISH). Anaerobe 17: 478–482.
• Bhute S, Pande P, Shetty SA, Shelar R, Mane S, Kumbhare SV, Gawali A, Makhani H, Navandar M, Dhotre D et al. (2016) Molecular Characteriza‑ tion and Meta‑Analysis of Gut Microbial Communities Illustrate Enrich‑ ment of Prevotella and Megasphaera in Indian Subjects. Front Microbiol 7: 660.
• Bocci V (1992) The neglected organ: bacterial flora has a crucial immuno‑ stimulatory role. Perspect Biol Med 35: 251–260.
• Braniste V, Al‑Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, Korecka A, Bakocevic N, Ng LG, Kundu P et al. (2014) The gut microbiota influences blood‑brain barrier permeability in mice. Sci Transl Med 6: 263ra158.
• Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci 108: 16050–16055.
• Bravo JA, Julio‑Pieper  M, Forsythe P, Kunze  W, Dinan TG, Bienenstock J, Cryan JF (2012) Communication between gastrointestinal bacteria and the nervous system. Curr Opin Pharmacol 12: 667–672.
• Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ (2008) Inflammatory markers in late‑life depression: re‑ sults from a population‑based study. J Affect Disord 106: 249–255.
• Brock M, Buckel W (2004) On the mechanism of action of the antifungal agent propionate. Eur J Biochem 271: 3227–3241.
• Buie T, Campbell DB, Fuchs GJ 3rd, Furuta GT, Levy J, Vandewater J, Whitaker AH, Atkins D, Bauman ML, Beaudet AL et al. (2010) Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 125 Suppl 1: S1–18.
• Burger‑van Paassen N, Vincent A, Puiman PJ, van der Sluis  M, Bouma J, Boehm G, van Goudoever JB, van Seuningen I, Renes IB (2009) The reg‑ ulation of intestinal mucin MUC2 expression by short‑chain fatty acids: implications for epithelial protection. Biochem J 420: 211–219.
• Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761–1772.
• Carlino D, De Vanna  M, Tongiorgi E (2013) Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions? Neuroscientist 19: 345–353.
• Cascella NG, Kryszak D, Bhatti B, Gregory P, Kelly DL, Mc Evoy JP, Fasano A, Eaton WW (2011) Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effective‑ ness study population. Schizophr Bull 37: 94–100.
• Caso JR, Balanza‑Martinez V, Palomo T, Garcia‑Bueno B (2016) The microbiota and gut‑brain axis: contributions to the immunopathogenesis of schizophrenia. Curr Pharm Des 22: 6122–6133.
• Critchfield JW, van Hemert S, Ash M, Mulder L, Ashwood P (2011) The po‑ tential role of probiotics in the management of childhood autism spec‑ trum disorders. Gastroenterol Res Pract 2011: 161358.
• Crow TJ (1980) Molecular pathology of schizophrenia: more than one dis‑ ease process? Br Med J 280: 66–68.
• Cryan JF, Dinan TG (2012) Mind‑altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13: 701–712.
• Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9: 46–56.
• Dash S, Clarke G, Berk M, Jacka FN (2015) The gut microbiome and diet in psychiatry: focus on depression. Curr Opin Psychiatry 28: 1–6.
• de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adapta‑ tion to disease. Nat Rev Neurosci 6: 463–475.
• de La Serre CB, de Lartigue G, Raybould HE (2015) Chronic exposure to low dose bacterial lipopolysaccharide inhibits leptin signaling in vagal afferent neurons. Physiol Behav 139: 188–194.
• de Lartigue G, Barbier de la Serre C, Espero E, Lee J, Raybould HE (2012) Leptin resistance in vagal afferent neurons inhibits cholecystokinin sig‑ naling and satiation in diet induced obese rats. PLoS One 7: e32967.
• Del Rosario A, McDermott MM, Panee J (2012) Effects of a high‑fat diet and bamboo extract supplement on anxiety‑ and depression‑like neurobe‑ haviours in mice. Br J Nutr 108: 1143–1149.
• DellaGioia N, Hannestad J (2010) A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev 34: 130–143.
• Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG (2010) Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170: 1179–1188.
• Desbonnet L, Clarke G, Shanahan F, Dinan TG, Cryan JF (2014) Microbio‑ ta is essential for social development in the mouse. Mol Psychiatry 19: 146–148.
• Desbonnet  L, Clarke G, Traplin A, O’Sullivan O, Crispie F, Moloney RD, Cotter PD, Dinan TG, Cryan JF (2015) Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour. Brain Behav Immun 48: 165–173.
• Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yang S, Yolken R (2013) C‑reactive protein is elevated in schizophrenia. Schizo‑ phr Res 143: 198–202
• Dickerson FB, Stallings C, Origoni A, Katsafanas E, Savage CL, Schweinfurth LA, Goga J, Khushalani S, Yolken RH (2014) Effect of probi‑ otic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a  randomized, placebo‑controlled trial. Prim Care Companion CNS Disord 16. pii: PCC.13m01579.
• DiGiulio DB (2012) Diversity of microbes in amniotic fluid. Semin Fetal Neonatal Med 17: 2–11.
• Dinan TG, Cryan JF (2013) Melancholic microbes: a link between gut micro‑ biota and depression? Neurogastroenterol Motil 25: 713–719.
• Dinan TG, Borre YE, Cryan JF (2014) Genomics of schizophrenia: time to consider the gut microbiome? Mol Psychiatry 19: 1252–1257.
• Dome P, Teleki Z, Rihmer Z, Peter L, Dobos J, Kenessey I, Tovari J, Timar J, Paku S, Kovacs G, Dome B (2009) Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul. Mol Psy‑ chiatry 14: 523–531.
• Douglas‑Escobar M, Elliott E, Neu J (2013) Effect of intestinal microbial ecol‑ ogy on the developing brain. JAMA Pediatr 167: 374–379.
• Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010) A meta‑analysis of cytokines in major depression. Biol Psychiatry 67: 446–457. Dunn AJ, Swiergiel AH (2005) Effects of interleukin‑1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol Biochem Be‑ hav 81: 688–693.
• Elson CO, Alexander KL (2015) Host‑microbiota interactions in the intes‑ tine. Dig Dis 33: 131–136.
• Emanuele E, Orsi P, Boso M, Broglia D, Brondino N, Barale F, di Nemi SU, Politi P (2010) Low‑grade endotoxemia in patients with severe autism. Neurosci Lett 471: 162–165.
• Ercolini D, Francavilla R, Vannini  L, De Filippis F, Capriati T, Di Cagno R, Iacono G, De Angelis M, Gobbetti M (2015) From an imbalance to a new imbalance: Italian‑style gluten‑free diet alters the salivary microbiota and metabolome of African celiac children. Sci Rep 5: 18571.
• Erridge C, Attina T, Spickett CM, Webb DJ (2007) A high‑fat meal induces low‑grade endotoxemia: evidence of a novel mechanism of postprandi‑ al inflammation. Am J Clin Nutr 86: 1286–1292.
• Evrensel A, Ceylan ME (2016) Fecal Microbiota Transplantation and Its Us‑ age in Neuropsychiatric Disorders. Clin Psychopharmacol Neurosci 14: 231–237.
• Fallani M, Young D, Scott J, Norin E, Amarri S, Adam R, Aguilera M, Khanna S, Gil A, Edwards CA, Dore J, Other Members of the IT (2010) Intestinal microbiota of 6‑week‑old infants across Europe: geographic influence beyond delivery mode, breast‑feeding, and antibiotics. J Pediatr Gastro‑ enterol Nutr 51: 77–84.
• Fallani  M, Amarri S, Uusijarvi A, Adam R, Khanna S, Aguilera  M, Gil A, Vieites JM, Norin E, Young D, Scott JA, Dore J, Edwards CA, team I (2011) Determinants of the human infant intestinal microbiota after the intro‑ duction of first complementary foods in infant samples from five Euro‑ pean centres. Microbiology 157: 1385–1392.
• Fan W, Huo G, Li X, Yang L, Duan C (2014) Impact of diet in shaping gut microbiota revealed by a  comparative study in infants during the six months of life. J Microbiol Biotechnol 24: 133–143.
• Fanaro S, Chierici R, Guerrini P, Vigi  V (2003) Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 91: 48–55.
• Fillman SG, Weickert TW, Lenroot RK, Catts SV, Bruggemann JM, Catts VS, Weickert CS (2016) Elevated peripheral cytokines characterize a  sub‑ group of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume. Mol Psychiatry 21: 1090–1098.
• Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, McTeague M, Sandler R, Wexler H, Marlowe EM, Collins MD, Lawson PA, Summanen P, Baysallar M, Tomzynski TJ, Read E, Johnson E, Rolfe R, Nasir P, Shah H, Haake DA, Manning P, Kaul A (2002) Gastrointestinal microflora studies in late‑onset autism. Clin Infect Dis 35: S6‑S16.
• Finegold SM, Dowd SE, Gontcharova  V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, Liu M, Molitoris DR, Green JA 3rd (2010) Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16: 444–453.
• Flint HJ (2012) The impact of nutrition on the human microbiome. Nutr Rev 70 Suppl 1: S10–13.
• Fond G, Boukouaci W, Chevalier G, Regnault A, Eberl G, Hamdani N, Dicker‑ son F, Macgregor A, Boyer L, Dargel A, Oliveira J, Tamouza R, Leboyer M (2015) The “psychomicrobiotic”: Targeting microbiota in major psychiat‑ ric disorders: A systematic review. Pathol Biol 63: 35–42.
• Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J (2010) Mood and gut feelings. Brain Behav Immun 24: 9–16.
• Foster JA, McVey Neufeld KA (2013) Gut‑brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36: 305–312.
• Furlano RI, Anthony A, Day R, Brown A, McGarvey L, Thomson MA, Davies SE, Berelowitz M, Forbes A, Wakefield AJ, Walker‑Smith JA, Murch SH (2001) Colonic CD8 and gamma delta T‑cell infiltration with epithelial damage in children with autism. J Pediatr 138: 366–372.
• Garcia‑Rodenas CL, Bergonzelli GE, Nutten S, Schumann A, Cherbut C, Turini M, Ornstein K, Rochat F, Corthesy‑Theulaz I (2006) Nutritional ap‑ proach to restore impaired intestinal barrier function and growth after neonatal stress in rats. J Pediatr Gastroenterol Nutr 43: 16–24.
• Gareau MG, Jury J, MacQueen G, Sherman PM, Perdue MH (2007) Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 56: 1522–1528.
• Garrett WS, Lord GM, Punit S, Lugo‑Villarino G, Mazmanian SK, Ito S, Glickman JN, Glimcher LH (2007) Communicable ulcerative colitis in‑ duced by T‑bet deficiency in the innate immune system. Cell 131: 33–45.
• Girard SA, Bah TM, Kaloustian S, Lada‑Moldovan L, Rondeau I, Tompkins TA, Godbout R, Rousseau G (2009) Lactobacillus helveticus and Bifidobacte‑ rium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. Br J Nutr 102: 1420–1425.
• Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR (1997) Au‑ ditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 54: 159–165.
• Gondalia SV, Palombo EA, Knowles SR, Cox SB, Meyer D, Austin DW (2012) Molecular characterisation of gastrointestinal microbiota of children with autism (with and without gastrointestinal dysfunction) and their neurotypical siblings. Autism Res 5: 419–427.
• Grenham S, Clarke G, Cryan JF, Dinan TG (2011) Brain‑gut‑microbe commu‑ nication in health and disease. Front Physiol 2: 94.
• Grigoleit JS, Kullmann JS, Wolf OT, Hammes F, Wegner A, Jablonowski S, Engler H, Gizewski E, Oberbeck R, Schedlowski M (2011) Dose‑depen‑ dent effects of endotoxin on neurobehavioral functions in humans. PLoS One 6: e28330.
• Haba R, Shintani N, Onaka Y, Wang H, Takenaga R, Hayata A, Baba A, Hashimoto H (2012) Lipopolysaccharide affects exploratory behaviors toward novel objects by impairing cognition and/or motivation in mice: Possible role of activation of the central amygdala. Behav Brain Res 228: 423–431.
• Hannestad J, DellaGioia N, Bloch  M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a me‑ ta‑analysis. Neuropsychopharmacology 36: 2452–2459.
• Hemmings G (2004) Schizophrenia. Lancet 364: 1312–1313.
• Hestad KA, Tonseth S, Stoen CD, Ueland T, Aukrust P (2003) Raised plasma levels of tumor necrosis factor alpha in patients with depression: nor‑ malization during electroconvulsive therapy. J ECT 19: 183–188.
• Hidaka BH (2012) Depression as a disease of modernity: explanations for increasing prevalence. J Affect Disord 140: 205–214.
• Holtzheimer PE, 3rd, Nemeroff CB (2006) Future prospects in depression research. Dialogues Clin Neurosci 8: 175–189.
• Hope S, Ueland T, Steen NE, Dieset I, Lorentzen S, Berg AO, Agartz I, Aukrust P, Andreassen OA (2013) Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophr Res 145: 36–42
• Hornig M (2013) The role of microbes and autoimmunity in the pathogene‑ sis of neuropsychiatric illness. Curr Opin Rheumatol 25: 488–795.
• Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C‑reactive protein, IL‑1, and IL‑6: a meta‑analysis. Psychosom Med 71: 171–186.
• Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK (2013) Microbiota modulate behavioral and physiological abnormalities associ‑ ated with neurodevelopmental disorders. Cell 155: 1451–1463.
• Hu X, Wang T, Jin F (2016) Alzheimer’s disease and gut microbiota. Sci China Life Sci 59: 1006–1023.
• Hudson ZD, Miller BJ (2016) Meta-analysis of cytokine and chemokine genes in schizophrenia. Clin Schizophr Relat Psychoses doi: 10.3371/ CSRP.HUMI.070516.
• Hugenholtz P, Goebel BM, Pace NR (1998) Impact of culture‑independent studies on the emerging phylogenetic view of bacterial diversity. J Bac‑ teriol 180: 4765–4774.
• Jackson JR, Eaton WW, Cascella NG, Fasano A, Kelly DL (2012) Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatr Q 83: 91–102.
• Jeffery IB, O’Toole PW, Ohman  L, Claesson MJ, Deane J, Quigley EM, Simren M (2012) An irritable bowel syndrome subtype defined by spe‑ cies‑specific alterations in faecal microbiota. Gut 61: 997–1006.
• Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang W, Tan Z, Shi J, Li L, Ruan B (2015) Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 48: 186–194.
• Johnson DR, O’Connor JC, Dantzer R, Freund GG (2005) Inhibition of va‑ gally mediated immune‑to‑brain signaling by vanadyl sulfate speeds recovery from sickness. Proc Natl Acad Sci 102: 15184–15189.
• Joseph J, Depp C, Shih PB, Cadenhead KS, Schmid‑Schonbein G (2017) Modified mediterranean diet for enrichment of short chain fatty acids: potential adjunctive therapeutic to target immune and metabolic dys‑ function in schizophrenia? Front Neurosci 11: 155.
• Julio‑Pieper M, Bravo JA, Aliaga E, Gotteland M (2014) Review article: intes‑ tinal barrier dysfunction and central nervous system disorders – a con‑ troversial association. Aliment Pharmacol Ther 40: 1187–1201.
• Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, Krakoff J (2011) Energy‑balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J  Clin Nutr 94: 58–65.
• Jyonouchi H, Sun S, Itokazu N (2002) Innate immunity associated with inflammatory responses and cytokine production against common di‑ etary proteins in patients with autism spectrum disorder. Neuropsycho‑ biology 46: 76–84.
• Kang DW, Park JG, Ilhan ZE, Wallstrom G, Labaer J, Adams JB, Krajmalnik‑Brown R (2013) Reduced incidence of Prevotella and oth‑ er fermenters in intestinal microflora of autistic children. PLoS One 8: e68322.
• Karakula‑Juchnowicz H, Szachta P, Opolska A, Morylowska‑Topolska J, Galecka M, Juchnowicz D, Krukow P, Lasik Z (2014) The role of IgG hy‑ persensitivity in the pathogenesis and therapy of depressive disorders. Nutr Neurosci 20: 110–118.
• Karakula‑Juchnowicz H, Dzikowski  M, Pelczarska A, Dzikowska I, Juchnowicz D (2016) The brain‑gut axis dysfunctions and hypersensitiv‑ ity to food antigens in the etiopathogenesis of schizophrenia. Psychiatr Pol 50: 747–760.
• Karlsson H, Blomstrom A, Wicks S, Yang S, Yolken RH, Dalman C (2012) Ma‑ ternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring. Am J Psychiatry 169: 625–632.
• Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI (2011) Human nutri‑ tion, the gut microbiome and the immune system. Nature 474: 327–336.
• Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG (1996) Comorbidity of DSM‑III‑R major depressive disorder in the general pop‑ ulation: results from the US National Comorbidity Survey. Br J Psychiatry Suppl: 17–30.
• Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age‑of‑onset distributions of DSM‑IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 593–602.
• Kim B, Hong VM, Yang J, Hyun H, Im JJ, Hwang J, Yoon S, Kim JE (2016) A review of fermented foods with beneficial effects on brain and cog‑ nitive function. Prev Nutr Food Sci 21: 297–309.
• King MD, Bearman PS (2011) Socioeconomic Status and the Increased Prevalence of Autism in California. Am Sociol Rev 76: 320–346.
• Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, Angenent  LT, Ley RE (2011) Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci 108 Suppl 1: 4578–4585.
• Kraeuter AK, Loxton H, Lima BC, Rudd D, Sarnyai Z (2015) Ketogenic diet re‑ verses behavioral abnormalities in an acute NMDA receptor hypofunc‑ tion model of schizophrenia. Schizophr Res 169: 491–493.
• Kurokawa K, Itoh T, Kuwahara T, Oshima K, Toh H, Toyoda A, Takami H, Morita H, Sharma VK, Srivastava TP, Taylor TD, Noguchi H, Mori H, Ogura  Y, Ehrlich DS, Itoh K, Takagi T, Sakaki Y, Hayashi T, Hattori  M (2007) Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 14: 169–181.
• Latalova K, Hajda M, Prasko J (2017) Can gut microbes play a role in mental disorders and their treatment? Psychiatr Danub 29: 28–30.
• Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci 102: 11070–11075.
• Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022–1023.
• Li  W, Dowd SE, Scurlock B, Acosta‑Martinez  V, Lyte  M (2009a) Memory and learning behavior in mice is temporally associated with diet‑in‑ duced alterations in gut bacteria. Physiol Behav 96: 557–567.
• Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, Malik M (2009b) Elevated immune response in the brain of autistic patients. J Neuroimmunol 207: 111–116.
• Liu F, Guo X, Wu R, Ou J, Zheng Y, Zhang B, Xie L, Zhang L, Yang L, Yang S, Yang J, Ruan Y, Zeng Y, Xu X, Zhao J (2014) Minocycline supplementa‑ tion for treatment of negative symptoms in early‑phase schizophre‑ nia: a double blind, randomized, controlled trial. Schizophr Res 153: 169–176.
• Luna RA, Foster JA (2015) Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression. Curr Opin Bio‑ technol 32: 35–41.
• Macdonald TT, Monteleone G (2005) Immunity, inflammation, and allergy in the gut. Science 307: 1920–1925.
• MacFabe DF, Cain DP, Rodriguez‑Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP (2007) Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disor‑ ders. Behav Brain Res 176: 149–169.
• Macpherson AJ, Harris NL (2004) Interactions between commensal intes‑ tinal bacteria and the immune system. Nat Rev Immunol 4: 478–485.
• Maes  M, Bosmans E, Suy E, Vandervorst C, De Jonckheere C, Raus J (1990) Immune disturbances during major depression: upregulat‑ ed expression of interleukin‑2 receptors. Neuropsychobiology 24: 115–120.
• Maes M, Bosmans E, Suy E, Vandervorst C, DeJonckheere C, Raus J (1991) Depression‑related disturbances in mitogen‑induced lymphocyte re‑ sponses and interleukin‑1 beta and soluble interleukin‑2 receptor pro‑ duction. Acta Psychiatr Scand 84: 379–386.
• Maes M (1993) A review on the acute phase response in major depression. Rev Neurosci 4: 407–416.
• Maes M (2011) An intriguing and hitherto unexplained co‑occurrence: De‑ pression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Prog Neuro‑ psychopharmacol Biol Psychiatry 35: 784–794.
• Mangiola F, Ianiro G, Franceschi F, Fagiuoli S, Gasbarrini G, Gasbarrini A (2016) Gut microbiota in autism and mood disorders. World J Gastro‑ enterol 22: 361–368.
• Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K (2014) Gut mi‑ crobes and the brain: paradigm shift in neuroscience. J Neurosci 34: 15490–15496.
• Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, Bisson JF, Rougeot C, Pichelin M, Cazaubiel M, Cazaubiel JM (2011) Assessment of psychotropic‑like properties of a  probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and hu‑ man subjects. Br J Nutr 105: 755–764.
• Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta‑analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70: 663–671.
• Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu  W, De Hert  M (2013) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders – a systematic review and me‑ ta‑analysis. Schizophr Bull 39: 306–318.
• Moles L, Gomez M, Heilig H, Bustos G, Fuentes S, de Vos W, Fernandez L, Rodriguez JM, Jimenez E (2013) Bacterial diversity in meconium of preterm neonates and evolution of their fecal microbiota during the first month of life. PLoS One 8: e66986.
• Moos WH, Faller DV, Harpp DN, Kanara I, Pernokas J, Powers WR, Steliou K (2016) Microbiota and neurological disorders: a gut feeling. Biores Open Access 5: 137–145.
• Morris R, Griffiths O, Le Pelley ME, Weickert TW (2013) Attention to irrele‑ vant cues is related to positive symptoms in schizophrenia. Schizophr Bull 39: 575–582.
• Nanri A, Kimura Y, Matsushita Y, Ohta  M, Sato  M, Mishima N, Sasaki S, Mizoue T (2010) Dietary patterns and depressive symptoms among Jap‑ anese men and women. Eur J Clin Nutr 64: 832–839.
• Naseribafrouei A, Hestad K, Avershina E, Sekelja M, Linlokken A, Wilson R, Rudi K (2014) Correlation between the human fecal microbiota and de‑ pression. Neurogastroenterol Motil 26: 1155–1162.
• Nell S, Suerbaum S, Josenhans C (2010) The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 8: 564–577.
• Nemani K, Hosseini Ghomi R, McCormick B, Fan X (2015) Schizophrenia and the gut‑brain axis. Prog Neuropsychopharmacol Biol Psychiatry 56: 155–160.
• Neufeld KM, Kang N, Bienenstock J, Foster JA (2011) Reduced anxiety‑like behavior and central neurochemical change in germ‑free mice. Neuro‑ gastroenterol Motil 23: 255–264, e119.
• Nieto R, Kukuljan M, Silva H (2013) BDNF and schizophrenia: from neuro‑ development to neuronal plasticity, learning, and memory. Front Psy‑ chiatry 4: 45.
• Nishino R, Mikami K, Takahashi H, Tomonaga S, Furuse M, Hiramoto T, Aiba  Y, Koga Y, Sudo N (2013) Commensal microbiota modulate murine behaviors in a strictly contamination‑free environment con‑ firmed by culture‑based methods. Neurogastroenterol Motil 25: 521–528.
• Nowak A, Libudzisz Z (2006) Influence of phenol, p‑cresol and indole on growth and survival of intestinal lactic acid bacteria. Anaerobe 12: 80–84.
• O’Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, Cryan JF, Dinan TG (2009) Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychi‑ atric illnesses. Biol Psychiatry 65: 263–267.
• O’Mahony SM, Hyland NP, Dinan TG, Cryan JF (2011) Maternal separation as a  model of brain‑gut axis dysfunction. Psychopharmacology (Berl) 214: 71–88.
• Ohland CL, Kish L, Bell H, Thiesen A, Hotte N, Pankiv E, Madsen KL (2013) Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbi‑ ome. Psychoneuroendocrinology 38: 1738–1747.
• Onore C, Careaga M, Ashwood P (2012) The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26: 383–392.
• Pacheco A, Easterling WS, Pryer MW (1965) A pilot study of the ketogenic diet in schizophrenia. Am J Psychiatry 121: 1110–1111.
• Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO (2007) Development of the human infant intestinal microbiota. PLoS Biol 5: e177.
• Parracho HM, Bingham MO, Gibson GR, McCartney AL (2005) Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54: 987–991.
• Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE (2006) Factors influencing the compo‑ sition of the intestinal microbiota in early infancy. Pediatrics 118: 511–521.
• Principi N, Esposito S (2016) Gut microbiota and central nervous system development. J Infect 73: 536-546.
• Pulikkan J, Maji A, Dhakan DB, Saxena R, Mohan B, Anto MM, Agarwal N, Grace T, Sharma VK (2018) Gut microbial dysbiosis in Indian children with autism spectrum disorders. Microb Ecol doi: 10.1007/s00248–018–1176–2.
• Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons  N, Levenez F, Yamada T et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59–65.
• Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neu‑ rodegeneration. Glia 55: 453–462.
• Qiu J, Heller JJ, Guo X, Chen ZM, Fish K, Fu YX, Zhou L (2012) The aryl hydro‑ carbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36: 92–104.
• Rabinowitz J, Levine SZ, Garibaldi G, Bugarski‑Kirola D, Berardo CG, Kapur S (2012) Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data. Schizophr Res 137: 147–150.
• Rakoff‑Nahoum S, Paglino J, Eslami‑Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll‑like receptors is re‑ quired for intestinal homeostasis. Cell 118: 229–241.
• Rodino‑Janeiro BK, Alonso‑Cotoner C, Pigrau M, Lobo B, Vicario M, Santos J (2015) Role of corticotropin‑releasing factor in gastrointestinal permea‑ bility. J Neurogastroenterol Motil 21: 33–50.
• Rogers RC, McCann MJ (1993) Intramedullary connections of the gastric region in the solitary nucleus: a biocytin histochemical tracing study in the rat. J Auton Nerv Syst 42: 119–130.
• Salazar N, Lopez P, Valdes L, Margolles A, Suarez A, Patterson AM, Cuervo A, de los Reyes‑Gavilan CG, Ruas‑Madiedo P, Gonzalez S, Gueimonde  M (2013) Microbial targets for the development of functional foods accord‑ ingly with nutritional and immune parameters altered in the elderly. J Am Coll Nutr 32: 399–406.
• Salazar N, Arboleya S, Valdes L, Stanton C, Ross P, Ruiz L, Gueimonde M, de Los Reyes‑Gavilan CG (2014) The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alter‑ ations. Front Genet 5: 406.
• Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Vaisanen ML, Nelson MN, Wexler HM (2000) Short‑term benefit from oral vancomycin treatment of regressive‑onset autism. J Child Neurol 15: 429–435.
• Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gas‑ troenterology 134: 577–594.
• Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, Day R (1986) Early manifestations and first‑contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychol Med 16: 909–928.
• Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S, Weidler EM, Qin X, Coarfa C, Milosavljevic A, Petrosino JF, Highlander S, Gibbs R, Lynch SV, Shulman RJ, Versalovic J (2011) Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastro‑ enterology 141: 1782–1791.
• Selhub EM, Logan AC, Bested AC (2014) Fermented foods, microbiota, and mental health: ancient practice meets nutritional psychiatry. J  Physiol Anthropol 33: 2.
• Sen T, Cawthon CR, Ihde BT, Hajnal A, DiLorenzo PM, de La Serre CB, Czaja K (2017) Diet‑driven microbiota dysbiosis is associated with vagal remodeling and obesity. Physiol Behav 173: 305–317.
• Serino M, Luche E, Gres S, Baylac A, Bergé M, Cenac C, Waget A, Klopp P, Iacovoni J, Klopp C, Mariette J, Bouchez O, Lluch J, Ouarné F, Monsan P, Valet P, Roques C, Amar J, Bouloumié A, Théodorou V, Burcelin R (2012) Metabolic adaptation to a high‑fat diet is associated with a change in the gut microbiota. Gut 61: 543–553.
• Severance EG, Dickerson FB, Halling  M, Krivogorsky B, Haile  L, Yang  S, Stallings CR, Origoni AE, Bossis I, Xiao J, Dupont D, Haasnoot  W, Yolken RH (2010) Subunit and whole molecule specificity of the anti‑bo‑ vine casein immune response in recent onset psychosis and schizophre‑ nia. Schizophr Res 118: 240–247.
• Severance EG, Alaedini A, Yang S, Halling  M, Gressitt KL, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Leweke FM, Dickerson FB, Yolken RH (2012) Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr Res 138: 48–53.
• Severance EG, Gressitt KL, Stallings CR, Origoni AE, Khushalani S, Leweke FM, Dickerson FB, Yolken RH (2013) Discordant patterns of bac‑ terial translocation markers and implications for innate immune imbal‑ ances in schizophrenia. Schizophr Res 148: 130–137.
• Shaw  W (2010) Increased urinary excretion of a  3‑(3‑hydroxy‑ phenyl)‑3‑hydroxypropionic acid (HPHPA), an abnormal phenylal‑ anine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. Nutr Neurosci 13: 135–143.
• Shultz SR, MacFabe DF, Ossenkopp KP, Scratch S, Whelan J, Taylor R, Cain  DP (2008) Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end‑product, impairs social behavior in the rat: implications for an animal model of autism. Neuropharmacology 54: 901–911.
• Sluzewska A, Rybakowski JK, Laciak  M, Mackiewicz A, Sobieska  M, Wiktorowicz K (1995) Interleukin‑6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 762: 474–476.
• Soczynska JK, Mansur RB, Brietzke E, Swardfager  W, Kennedy SH, Woldeyohannes HO, Powell AM, Manierka MS, McIntyre RS (2012) Nov‑ el therapeutic targets in depression: minocycline as a candidate treat‑ ment. Behav Brain Res 235: 302–317.
• Song Y, Liu C, Finegold SM (2004) Real‑time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 70: 6459–6465.
• Stappenbeck TS, Hooper LV, Gordon JI (2002) Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 99: 15451–15455.
• Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y (2004) Postnatal microbial colonization programs the hypothalam‑ ic‑pituitary‑adrenal system for stress response in mice. J Physiol 558: 263–275.
• Szkultecka-Dębek M, Miernik K, Stelmachowski J, Jakovljević M, Jukić V, Aadamsoo K, Janno S, Bitter I, Tolna J, Jarema M, Jankovic S, Pecenak J, Vavrusova L, Tavčar R, Walczak J, Talbot D, Augustyńska J (2016) Schizo‑ phrenia causes significant burden to patients’ and caregivers’ lives. Psy‑ chiatr Danub 28: 104–110.
• Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi  M, Weng Z, Miniati A, Kalogeromitros D (2012) Mast cells and inflammation. Biochim Biophys Acta 1822: 21–33.
• Theoharides TC, Asadi S, Patel AB (2013) Focal brain inflammation and au‑ tism. J Neuroinflammation 10: 46.
• Thomas V, Clark J, Dore J (2015) Fecal microbiota analysis: an overview of sample collection methods and sequencing strategies. Future Microbiol 10: 1485–1504.
• Tillisch K, Labus J, Kilpatrick  L, Jiang Z, Stains J, Ebrat B, Guyonnet D, Legrain‑Raspaud S, Trotin B, Naliboff B, Mayer EA (2013) Consumption of fermented milk product with probiotic modulates brain activity. Gas‑ troenterology 144: 1394–1401.
• Torrente F, Ashwood P, Day R, Machado N, Furlano RI, Anthony A, Davies  SE, Wakefield AJ, Thomson MA, Walker‑Smith JA, Murch SH (2002) Small intestinal enteropathy with epithelial IgG and comple‑ ment deposition in children with regressive autism. Mol Psychiatry 7: 375–382, 334.
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini  V, Mardis ER, Gordon JI (2006) An obesity‑associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027–1031.
• Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1: 6ra14.
• Turroni F, Ribbera A, Foroni E, van Sinderen D, Ventura M (2008) Human gut microbiota and bifidobacteria: from composition to functionality. Antonie Van Leeuwenhoek 94: 35–50.
• Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57: 67–81.
• Vaughn AC, Cooper EM, DiLorenzo PM, O’Loughlin LJ, Konkel ME, Peters JH, Hajnal A, Sen T, Lee SH, de La Serre CB, Czaja K (2017) Energy‑dense diet triggers changes in gut microbiota, reorganization of gutbrain vagal communication and increases body fat accumulation. Acta Neurobiol Exp 77: 18–30.
• Wajner M, Latini A, Wyse AT, Dutra‑Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from ani‑ mal studies. J Inherit Metab Dis 27: 427–448.
• Walker EF, Diforio D (1997) Schizophrenia: a neural diathesis‑stress model. Psychol Rev 104: 667–685.
• Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA (2012) Elevated fecal short chain fatty acid and ammonia concen‑ trations in children with autism spectrum disorder. Dig Dis Sci 57: 2096–2102.
• Wang X, Wang BR, Zhang XJ, Xu Z, Ding YQ, Ju G (2002) Evidences for vagus nerve in maintenance of immune balance and transmission of immune information from gut to brain in STM‑infected rats. World J Gastroen‑ terol 8: 540–545.
• Wang Y, Kasper LH (2014) The role of microbiome in central nervous sys‑ tem disorders. Brain Behav Immun 38: 1–12.
• Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G (2009) Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci 106: 3698–3703.
• Williams BL, Hornig M, Buie T, Bauman ML, Cho Paik M, Wick I, Bennett A, Jabado O, Hirschberg DL, Lipkin WI (2011) Impaired carbohydrate diges‑ tion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One 6: e24585.
• Williams SC (2012) Genetics: Searching for answers. Nature 491: S4–6.
• Zhou L, Foster JA (2015) Psychobiotics and the gut‑brain axis: in the pursuit of happiness. Neuropsychiatr Dis Treat 11: 715–723.
• Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K (2001) The relationship of depression and stressors to immunological assays: a meta‑analytic review. Brain Behav Immun 15: 199–226.

Identyfikatory

DOI

10.21307/ane‑2018‑008